RULE NO.: RULE TITLE:
61D-6.008: Permitted Medications for Horses

Notice is hereby given that the following changes have been made to the proposed rule in accordance with subparagraph 120.54(3)(d)1., F.S., published in Vol. 36 No. 36, September 10, 2010 issue of the Florida Administrative Weekly.

61D-6.008 Permitted Medications for Horses.

(1) through (2)(a)1. No change.

2. The post race serum sample of such horse contains a concentration less than 2 5 micrograms (mcg) of phenylbutazone or its metabolites per milliliter (ml) of serum.

(b) When the post race serum sample of such horse contains a concentration of phenylbutazone equal to or in excess of 2 micrograms per milliliter of serum, but less than 5 8 micrograms per milliliter of serum, the trainer as the absolute insurer of the horse, shall be subject to the following penalties:

1. through 3. No change.

(c) When the post race serum sample contains a concentration of phenylbutazone equal to or in excess of 5 8 micrograms per milliliter of serum, the trainer as the absolute insurer of the horse, shall be subject to the following penalties:

1. through 3. No change.

(3) through (8) No change.

(9) The following permitted medications shall not be reported by the racing laboratory to the division as a violation of Section 550.2415, F.S.:

(a) The detection of cimetidine at a urinary concentration less than or equal to 10 micrograms per milliliter.

(a)(b) The detection of dimethyl sulfoxide (DMSO) at a blood serum concentration less than or equal to 10 micrograms per milliliter.

(c) The detection of famotidine at a urinary concentration less than or equal to 10 micrograms per milliliter.

(b)(d) The detection of flunixin at a blood serum concentration less than or equal to 20 nanograms per milliliter.

(c)(e) The detection of guaifenesin (free) at a blood serum concentration less than or equal to 100 nanograms per milliliter.

(d)(f) The detection of total isoxsuprine at a urinary concentration less than or equal to 100 nanograms per milliliter.

(e)(g) The detection of ketoprofen at a blood serum concentration less than or equal to 10 nanograms per milliliter.

(f)(h) The detection of methocarbamol (free) at a blood serum concentration less than or equal to 20 nanograms per milliliter.

(g)(i) The detection of naproxen at a blood serum concentration less than or equal to 1 microgram per milliliter.

(j) The detection of a sulfide metabolite of omeprazole detected by LC-MS.

(k) The detection of ranitidine at a urinary concentration less than or equal to 10 micrograms per milliliter.

(10) No change.

Rulemaking Authority 550.0251(3), 550.2415(7)(a), (b), (c), (e), (8)(c), (12) FS. Law Implemented 550.0251(11), 550.2415(1), (7)(8)(e), (8)(9)(c), (12)(13), (14)(15), (15)(16) FS. History–New 10-20-96, Amended 1-5-98, 6-6-00, 5-14-02, 6-6-04, 7-6-06, 8-12-07, 12-30-08,________.